DIAMOX

This brand name is authorized in Australia, Austria, Brazil, Croatia, Estonia, France, Ireland, Japan, Netherlands, New Zealand, Tunisia, UK.

Active ingredients

The drug DIAMOX contains one active pharmaceutical ingredient (API):

1
UNII O3FX965V0I - ACETAZOLAMIDE
 

Acetazolamide is an enzyme inhibitor which acts specifically on carbonic anhydrase. By inhibiting the reaction catalysed by this enzyme in the renal tubules, acetazolamide increases the excretion of bicarbonate and of cations, chiefly sodium and potassium, and so promotes alkaline diuresis. By inhibiting carbonic anhydrase in the eye acetazolamide decreases intra-ocular pressure and is therefore useful in the treatment of glaucoma.

 
Read more about Acetazolamide

Medication package inserts

Below package inserts are available for further reading:

Document Type Information Source  
 DIAMOX Sodium Powder for solution for injection MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)
 DIAMOX Tablet MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)
 DIAMOX SR Capsule MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
S01EC01 Acetazolamide S Sensory organs → S01 Ophthalmologicals → S01E Antiglaucoma preparations and miotics → S01EC Carbonic anhydrase inhibitors
Discover more medicines within S01EC01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
AU Pharmaceutical Benefits Scheme 1004W
BR Câmara de Regulação do Mercado de Medicamentos 533020501119410
EE Ravimiamet 1122321, 1312085, 1616116, 1715060, 1820641, 1853232
FR Base de données publique des médicaments 63463588, 68693244
GB Medicines & Healthcare Products Regulatory Agency 122090, 43709
HR Agencija za lijekove i medicinske proizvode HR-H-557475500
IE Health Products Regulatory Authority 21164, 21207, 23469
JP 医薬品医療機器総合機構 2134001X1029, 2134002F1109, 2134400D1039
NL Z-Index G-Standaard, PRK 4898, 817
NZ Medicines and Medical Devices Safety Authority 2184
TN Direction de la Pharmacie et du Médicament 3623091

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.